Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer

BACKGROUND: Lipid metabolic reprogramming in colon cancer shows a potential impact on tumor immune microenvironment and is associated with response to immunotherapy. Therefore, this study aimed to develop a lipid metabolism-related prognostic risk score (LMrisk) to provide new biomarkers and combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lilong, Mo, Min, Chen, Xuehan, Chao, Dongchen, Zhang, Yufan, Chen, Xuewei, Wang, Yang, Zhang, Nan, He, Nan, Yuan, Xi, Chen, Honglei, Yang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100168/
https://www.ncbi.nlm.nih.gov/pubmed/37055842
http://dx.doi.org/10.1186/s13046-023-02647-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100168/
https://www.ncbi.nlm.nih.gov/pubmed/37055842
http://dx.doi.org/10.1186/s13046-023-02647-8

Ejemplares similares